Panacea Biotec aims to make 1-bn doses of COVID-19 vaccine candidate in 2022
The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
EU raises its bet on blood plasma in search for COVID-19 therapy
The move also highlights the more assertive approach being taken by the 27-nation union in the race to find effective drugs and…
Lupin recalls diabetes treatment drug in US
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg…
Moderna signs deal with Spain’s Rovi to supply potential COVID-19 vaccine outside US
Moderna’s vaccine was among the first to be tested in humans in the United States and was found to produce protective antibodies…
Strides receives USFDA approval for headache drug
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules will be marketed by Strides Pharma in the US market
Future proofing of work function will be defined by a maturity model across three elements: IPA-BCG
In an article, ‘Future of Work: Building the future quality function’, the Indian Pharmaceutical Alliance (IPA) and Boston…
Biogen moves forward with potential Alzheimer’s drug, seeks US FDA’s approval
The drug, aducanumab, has had a tumultuous journey, with promising early data raising hopes and Biogen’s share price, only to be…
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
Coronavirus tricks the body into attacking brain; common heartburn drugs linked to coronavirus risk
Widely used heartburn drugs that have been linked with numerous complications including higher risk for kidney disease and…
Gilead begins testing inhalable form of remdesivir for COVID-19
The company said the trial will test the drug particularly in those cases where the disease has not progressed to require…